LLY Today - Jul 13: Analyst Upgrades Boost Sentiment

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

LLY Today - Jul 13: Analyst Upgrades Boost Sentiment

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor, here to break down how Eli Lilly did today. Spoiler alert: it was a bit of a green day, up just a smidge at 0.22%.

So, what happened? Well, LLY didn’t exactly have fireworks today, but it didn’t crash and burn either. It kinda just hung around, barely moving. The trading volume was way lower than usual, which usually means people weren’t really rushing to buy or sell.

Now, why did it move this way? A couple of things were buzzing in the news. Analysts are feeling pretty optimistic about Eli Lilly, especially with the buzz around their new weight-loss drugs and some recent data they presented at a conference. Guggenheim even raised their price target on the stock, which is usually a good sign. People are chatting about how these drugs could really change the game for investors, and that’s got some folks excited. But honestly, the stock’s not moving in wild swings like it has in the past. It seems like investors are kinda waiting to see what’s next.

Speaking of what's next, Eli Lilly's got some new data on a drug called Kisunla that they just presented. It’s creating a bit of a stir, so keep an eye on that. It could shake things up in the near future.

Alright, that’s the scoop for today! Eli Lilly is hanging in there, and it looks like analysts are still pretty positive. Just remember, this is all for fun and info—no financial advice here. Catch you later!

まだレビューはありません